Response to: Letter to the Editor from Fitzpatrick et al: "Zoledronate after denosumab discontinuation: Is repeated administrations more effective than single infusion?"
Giorgia GrassiAlberto GhielmettiMarta ZampognaIacopo ChiodiniArosio MauraMantovani GiovannaCristina Eller-VainicherPublished in: The Journal of clinical endocrinology and metabolism (2024)